Resveratrol Modulates the Topoisomerase Inhibitory Potential of Doxorubicin in Human Colon Carcinoma Cells

Resveratrol (RSV) is currently being widely discussed as potentially useful for anticancer therapy in combination with classical chemotherapeutics, e.g., the topoisomerase II (TOP II) poison doxorubicin (DOX). However, there is still a lack of knowledge of possible interference at the target enzyme,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeter, Anika, Marko, Doris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271354/
https://www.ncbi.nlm.nih.gov/pubmed/25470274
http://dx.doi.org/10.3390/molecules191220054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271354/
https://www.ncbi.nlm.nih.gov/pubmed/25470274
http://dx.doi.org/10.3390/molecules191220054

Ejemplares similares